Becton, Dickinson and Co. | BDX - Actif À Court Terme





Actif À Court Terme Changement Date
Abbott USD 23.5B 1.02B 2026-09
Agilent USD 4.69B 70M 2026-06
Align Technology USD 2.73B 63.03M 2026-09
AngioDynamics USD 161.35M 4.69M 2025-09
Baxter International USD 6.83B 163M 2026-09
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Bio-Rad Laboratories USD 3.08B 58.1M 2026-09
Boston Scientific USD 8.16B 192M 2026-09
Cooper Companies USD 2.28B 18.3M 2026-06
Danaher USD 14.79B 1.41B 2026-09
Dentsply International USD 1.98B 50M 2026-09
Dexcom USD 3.92B 170.6M 2026-09
Edwards Lifesciences USD 7.25B 428.6M 2026-09
Globus Medical USD 2.18B 33.55M 2026-09
Insulet USD 2.04B 192.4M 2026-09
Integra LifeSciences USD 1.19B 1.54M 2026-09
Intuitive Surgical USD 10.65B 1.68B 2026-09
J&J USD 56.35B 3.42B 2026-09
Medtronic USD 24.39B 397M 2026-06
Solventum Corp USD 3.69B 49M 2026-09
Stryker USD 14.18B 235M 2026-09
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teleflex USD 1.84B 31.2M 2026-09
Terumo JPY 906.6B 45.57B 2026-06
Thermo Fisher Scientific USD 25.62B 2.25B 2026-09
Zimmer Biomet Holdings USD 5.13B 32.3M 2026-09